These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 22504736)

  • 1. Personalised medicine in 2012: editorial to the special issue of New Biotechnology on "molecular diagnostics & personalised medicine".
    Desiere F; Romano Spica V
    N Biotechnol; 2012 Sep; 29(6):611-2. PubMed ID: 22504736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The triad of success in personalised medicine: pharmacogenomics, biotechnology and regulatory issues from a Central European perspective.
    Mesko B; Zahuczky G; Nagy L
    N Biotechnol; 2012 Sep; 29(6):741-50. PubMed ID: 22414700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beware the Medical-Industrial Complex.
    Stevens CW; Glatstein E
    Oncologist; 1996; 1(4):IV-V. PubMed ID: 10388005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microarrays: Molecular allergology and nanotechnology for personalised medicine (II).
    Lucas JM
    Allergol Immunopathol (Madr); 2010; 38(4):217-23. PubMed ID: 20537785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The promise of protein glycosylation for personalised medicine.
    Almeida A; Kolarich D
    Biochim Biophys Acta; 2016 Aug; 1860(8):1583-95. PubMed ID: 26987810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming regulatory and economic challenges facing pharmacogenomics.
    Cohen JP
    N Biotechnol; 2012 Sep; 29(6):751-6. PubMed ID: 22370122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
    Allen D; Rixson L
    Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The personalised medicine. A paradigm of evidence-based medicine.
    Kumar D
    Ann Ist Super Sanita; 2011; 47(1):31-40. PubMed ID: 21430336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Value of Companion Diagnostics: Overcoming Access Barriers to Transform Personalised Health Care into an Affordable Reality in Europe.
    Wurcel V; Perche O; Lesteven D; Williams DA; Schäfer B; Hopley C; Jungwirth R; Postulka A; Pasmans R; Hermansson LL; Ott M; Glorioso V
    Public Health Genomics; 2016; 19(3):137-43. PubMed ID: 27237134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New ways of insulin delivery.
    Heinemann L
    Int J Clin Pract Suppl; 2010 Feb; (166):29-40. PubMed ID: 20377662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalised treatment of haematological malignancies through systems medicine based on single molecules in single cells.
    Karimiani EG; Day P
    Integr Biol (Camb); 2013 May; 5(5):759-67. PubMed ID: 23532213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Personalised medicine' through 'personalised medicines': time to integrate advanced, non-invasive imaging approaches and smart drug delivery systems.
    Crommelin DJ; Storm G; Luijten P
    Int J Pharm; 2011 Aug; 415(1-2):5-8. PubMed ID: 21320581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Making personalized cancer medicine a reality: challenges and opportunities in the development of biomarkers and companion diagnostics.
    Parkinson DR; Johnson BE; Sledge GW
    Clin Cancer Res; 2012 Feb; 18(3):619-24. PubMed ID: 22298894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized medicine and therapeutic decision-making in oncology: a commentary on key environmental issues.
    Freeman RA
    J Oncol Pharm Pract; 2011 Sep; 17(3):295-7. PubMed ID: 20551112
    [No Abstract]   [Full Text] [Related]  

  • 15. [Special considerations for the regulation of biological medicinal products in individualised medicine. More than stratified medicine].
    Müller-Berghaus J; Volkers P; Scherer J; Cichutek K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1538-44. PubMed ID: 24170083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Internet and information technology use in treatment of diabetes.
    Kaufman N
    Int J Clin Pract Suppl; 2010 Feb; (166):41-6. PubMed ID: 20377663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public-private collaborations and partnerships in stratified medicine: making sense of new interactions.
    Chataway J; Fry C; Marjanovic S; Yaqub O
    N Biotechnol; 2012 Sep; 29(6):732-40. PubMed ID: 22446473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Personalised medicine. Paradigm shift within drug research and therapy].
    Stock G; Sydow S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1495-501. PubMed ID: 24170078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Individualisation of medicine: medical philosophy and societal implications of an ambiguous guiding principle].
    Kollek R
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(1):40-5. PubMed ID: 22325106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GeneNews Limited: bringing the blood transcriptome to personalized medicine.
    Novak DJ; Liew GJ; Liew CC
    Pharmacogenomics; 2012 Mar; 13(4):381-5. PubMed ID: 22379995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.